T144
(±)-Thalidomide
≥98%, powder
Manufacturer: Sigma Aldrich
CAS Number: 50-35-1
Synonym(S): (±)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 MG | T144-100-MG | In Stock | ₹ 10,410.00 |
| 1 G | T144-1-G | In Stock | ₹ 59,970.00 |
T144 - 100 MG
In Stock
Quantity
1
Base Price: ₹ 10,410.00
GST (18%): ₹ 1,873.80
Total Price: ₹ 12,283.80
ligand
thalidomide
Assay
≥98%
form
powder
reaction suitability
reagent type: ligand
color
white
solubility
DMSO: 20 mg/mL, clear
originator
Celgene
SMILES string
O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1
InChI
1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)
InChI key
UEJJHQNACJXSKW-UHFFFAOYSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | eMolecules Ambeed / 2-(26-Dioxopiperidin-3-yl)isoindoline-13-dione / 1mg / 713090201 / A164079 / / 50-35-1 / MFCD00153873 / 258.233 / C13H10N2O4 | eMolecules | ₹ 2,065.42 | |
 | Sigma Aldrich Fine Chemicals Biosciences Thalidomide United States Pharmacopeia (USP) Reference Standard | 50-35-1 | MFCD00153873 | 200MG | Sigma Aldrich Fine Chemicals Biosciences | ₹ 54,416.16 | |
 | Thalidomide | Sigma Aldrich | ₹ 48,398.58 | |
| | Thalidomide | Supelco | ₹ 16,194.20 | |
 | Thalidomide | ChemScene | ₹ 5,133.60 - ₹ 10,267.20 |
Related Products
Description
- Application: Thalidomide has been used to study its neuropathological effects in mouse models of Alzheimer′s disease (AD). This study reported that long term administration of thalidomide causes beta-secretase inhibition and subsequently alleviates amyloid-like pathology[1]. Furthermore, thalidomide has also been used to evaluate its teratogenic functions. Thalidomide was found to affect endodermal differentiation and neural development in differentiating human embryonic and induced pluripotent stem cells[2].
- Biochem/physiol Actions: (±)-Thalidomide selectively inhibits biosynthesis of tumor necrosis factor α (TNF-α). It also functions as an inhibitor of angiogenesis, an immunosuppressive agent, a sedative and a teratogen. Furthermore, thalidomide is known to exhibit antitumor functions in refractory multiple myeloma[3].
- Features and Benefits: This compound was developed by Celgene. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
- Preparation Note: Thalidomide is soluble in DMSO at a concentration that is more than 20 mg/ml. It is insoluble in water and ethanol.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P202 - P264 - P280 - P301 + P310 - P302 + P352 + P312 - P362 + P364
Hazard Classifications
Acute Tox. 3 Oral - Acute Tox. 4 Dermal - Repr. 1A
WGK
WGK 3
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Compare Similar Items
Show Difference
ligand: thalidomide
Assay: ≥98%
form: powder
reaction suitability: reagent type: ligand
color: white
solubility: DMSO: 20 mg/mL, clear
originator: Celgene
SMILES string: O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1
InChI: 1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)
InChI key: UEJJHQNACJXSKW-UHFFFAOYSA-N
ligand:
thalidomide
Assay:
≥98%
form:
powder
reaction suitability:
reagent type: ligand
color:
white
solubility:
DMSO: 20 mg/mL, clear
originator:
Celgene
SMILES string:
O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1
InChI:
1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)
InChI key:
UEJJHQNACJXSKW-UHFFFAOYSA-N
ligand: __
Assay: __
form: __
reaction suitability: __
color: __
solubility: __
originator: __
SMILES string: [H]\C(=C(/[H])C(O)=O)C(O)=O.CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2
InChI: 1S/C13H24N4O3S.C4H4O4/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17;5-3(6)1-2-4(7)8/h10,14,18H,4-9H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t10-;/m0./s1
InChI key: WLRMANUAADYWEA-NWASOUNVSA-N
ligand:
__
Assay:
__
form:
__
reaction suitability:
__
color:
__
solubility:
__
originator:
__
SMILES string:
[H]\C(=C(/[H])C(O)=O)C(O)=O.CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2
InChI:
1S/C13H24N4O3S.C4H4O4/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17;5-3(6)1-2-4(7)8/h10,14,18H,4-9H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b;2-1-/t10-;/m0./s1
InChI key:
WLRMANUAADYWEA-NWASOUNVSA-N
ligand: __
Assay: __
form: __
reaction suitability: __
color: __
solubility: __
originator: __
SMILES string: __
InChI: __
InChI key: __
ligand:
__
Assay:
__
form:
__
reaction suitability:
__
color:
__
solubility:
__
originator:
__
SMILES string:
__
InChI:
__
InChI key:
__
ligand: __
Assay: __
form: __
reaction suitability: __
color: __
solubility: __
originator: __
SMILES string: __
InChI: __
InChI key: __
ligand:
__
Assay:
__
form:
__
reaction suitability:
__
color:
__
solubility:
__
originator:
__
SMILES string:
__
InChI:
__
InChI key:
__